Chalcogen Bonded Directly To The Triazole Ring Patents (Class 514/384)
-
Publication number: 20100261680Abstract: The invention relates to herbicidal compositions, their preparation, and their use for controlling unwanted vegetation. The compositions include an effective amount of an active compound combination that includes: (a) a substituted thien-3-yl-sulphonylaminocarbonyltriazolinone of formula (I-2) or salts thereof; and (b) at least one of the known herbicides listed in the disclosure and, (c) optionally a safener.Type: ApplicationFiled: June 28, 2010Publication date: October 14, 2010Applicant: Bayer CropScience AGInventors: Dieter FEUCHT, Peter Dahmen, Mark Wilhelm Drewes, Rolf Pontzen, Ernst Rudolf F. Gesing
-
Publication number: 20100261771Abstract: The present application relates to new, substituted 2-acetamido-5-aryl-1,2,4-triazolones, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders.Type: ApplicationFiled: March 18, 2010Publication date: October 14, 2010Applicant: BAYER SCHERING PHARMA AKTIENGESELLSCHAFTInventors: Ulf Brüggemeier, Chantal Fürstner, Volker Geiss, Joerg Keldenich, Armin Kern, Martina Delbeck, Peter Kolkhof, Axel Kretschmer, Elisabeth Pook, Carsten Schmeck, Hubert Trübel
-
Patent number: 7807690Abstract: A compound represented by the following general formula (1), or a salt thereof has serine protease inhibiting activity, and particularly excellent inhibiting activity against clotting factor VIIa. This compound or a salt thereof is useful as therapeutic and/or prophylactic agents for diseases associated with thrombus formation. [wherein R1 represents hydrogen, R2 represents optionally substituted phenyl, etc., R3 represents optionally substituted C6-10 aryl, etc.].Type: GrantFiled: September 19, 2008Date of Patent: October 5, 2010Assignee: Eisai R&D Management Co., Ltd.Inventors: Richard Clark, Atsushi Takemura, Nobuhisa Watanabe, Osamu Asano, Tadashi Nagakura, Kimiyo Tabata
-
Publication number: 20100249185Abstract: The present invention relates to compounds that inhibit the activity of Hsp90 and inhibit topoisomerase II.Type: ApplicationFiled: March 11, 2008Publication date: September 30, 2010Inventors: Zhenjian Du, Minghu Song, Weiwen Ying
-
Patent number: 7799815Abstract: The present invention relates to novel compounds of formula (I) or a salt thereof: wherein: G is a 5- or 6-membered heteroaromatic group, or is a 9- or 10-membered bicyclic heteroaromatic group containing one or two heteroatoms independently selected from nitrogen and oxygen, wherein G is not pyridyl, indazolyl or benzothiazolyl; p is an integer ranging from 0 to 4; R1 is independently selected from a group consisting of: halogen, hydroxy, cyano, C1-4alkyl, haloC1-4alkyl, C1-4alkoxy, haloC1-4alkoxy, C1-4alkanoyl or SF5; or corresponds to a group R5; R2 is hydrogen or C1-4alkyl; n is 2 or 3; X is S or —CH2—; R3 is C1-4alkyl; R4 is hydrogen, or a phenyl group, a heterocyclyl group, a 5- or 6-membered heteroaromatic group, or a 8- to 11-membered bicyclic group, any of which groups is optionally substituted by 1, 2, 3 or 4 substituents selected from the group consisting of: halogen, cyano, C1-4alkyl, haloC1-4alkyl, C1-4alkoxy and C1-4alkanoyl; R5 is isoxazolyl, —CH2—N-pyrrolyl, 1,1-dioxido-2-isothiazolidinType: GrantFiled: August 18, 2006Date of Patent: September 21, 2010Assignee: Glaxo Group LimitedInventors: Giorgio Bonanomi, Romano Di Fabio, Elettra Fazzolari, Dieter Hamprecht, Fabrizio Micheli, Luca Tarsi, Silvia Terreni
-
Publication number: 20100233116Abstract: The present invention provides heterocyclic derivatives hat modulate the activity of stearoyl-CoA desaturase. Methods of using such derivatives to modulate the activity of stearoyl-CoA desaturase and pharmaceutical compositions comprising such derivatives are also encompassed.Type: ApplicationFiled: August 13, 2007Publication date: September 16, 2010Inventors: Natalie Dales, Julia Fonarev, Jianmin Fu, Rajender Kamboj, Vishnumurthy Kodumuru, Shifeng Liu, Natalia Pokrovskaia, Vandna Raina, Shaoyi Sun, Zaihui Zhang
-
Publication number: 20100222401Abstract: Compounds, compositions and methods for inhibiting vascular permeability and pathologic angiogenesis by modulating a signaling pathway delineated herein are described. Moreover, methods for producing and screening compounds and compositions capable of modulating the signaling pathway described herein, inhibiting vascular permeability, and inhibiting pathologic angiogenesis are also provided.Type: ApplicationFiled: April 16, 2009Publication date: September 2, 2010Applicant: University of Utah Research FoundationInventors: Dean Li, Christopher Jones, Nyall London
-
Patent number: 7772265Abstract: Novel compounds of the formula I in which R, X and n are as defined herein, are inhibitors of tyrosine kinase and can be employed for the treatment of tumours, for neuroprotection and for protection of the stress proteins of the skin.Type: GrantFiled: April 1, 2008Date of Patent: August 10, 2010Assignee: Merck Patent GmbHInventors: Teresa Mujica-Fernaud, Herwig Buchholz, Christophe Carola, Wilfried Rautenberg, Christian Sirrenberg
-
Publication number: 20100197696Abstract: The invention relates to compounds of formula wherein Het, A1, A2, A3, A4, D, W, T, Q, Y, X1, X2, R1, R2, R3, R4, k and m are as defined hereinabove, and, where applicable, to possible E/Z isomers, mixtures of E/Z isomers and/or tautomers thereof, in each case in free form or in salt form, to a process for the preparation of and to the use of those compounds, E/Z isomers, mixtures of E/Z isomers and/or tautomers, to pesticidal compositions in which the active ingredient has been selected from those compounds, E/Z isomers, mixtures of E/Z isomers and/or tautomers, in each case in free form or in agrochemically usable salt form, to a process for the preparation of and to the use of those compositions, to plant propagation material treated with those compositions, to a method of controlling pests, to intermediates and, where applicable, to possible E/Z isomers, mixtures of E/Z isomers and/or tautomers thereof, in each case in free form or in salt form, for the preparation of those compounds, E/Z isomers, mType: ApplicationFiled: April 8, 2010Publication date: August 5, 2010Applicant: SYNGENTA CROP PROTECTION, INC.Inventors: Roger Graham Hall, Stephan Trah, Werner Zambach, Juraj Tuleja
-
Publication number: 20100190783Abstract: A Compound represented by the following general formula (1): wherein R1a, R1b, R1c and R1d each independently represent hydrogen, etc.; R2 represents optionally substituted phenyl, etc.; R3 represents optionally substituted C6-10 aryl, etc.; and Z1 and Z2 each independently represent hydrogen or salts thereof or hydrates of the foregoing.Type: ApplicationFiled: March 29, 2010Publication date: July 29, 2010Inventors: Richard CLARK, Fumiyoshi MATSUURA, Kazunobu KIRA, Shinsuke HIROTA, Hiroshi AZUMA, Tadashi NAGAKURA, Tatsuo HORIZOE, Kimiyo TABATA, Kazutomi KUSANO, Takao OMAE, Atsushi INOUE
-
Patent number: 7745469Abstract: The invention relates to novel fungicidally active compound combinations of 2?-cyano-3,4-dichloroisothiazole-5-carboxanilide of the formula and active compounds listed in the disclosure.Type: GrantFiled: July 20, 2004Date of Patent: June 29, 2010Assignee: Bayer CropScience AGInventors: Peter Dahmen, Ulrike Wachendorff-Neumann, Rolf Pontzen, Lutz Aβmann, Haruko Sawada
-
Publication number: 20100160399Abstract: The invention relates to a fungicidal mixture comprising prothioconazole or a salt or adduct thereof with an inorganic acid an organic acid or a metal ion; and at least one further fungicidal compound, selected from the group consisting of thiram, fenoxanil, benthivalicarb, metalaxyl, fludioxonil and prochloraz, in a synergistically effective amount and to methods for controlling harmful fungi, comprising applying the fungicidal mixture.Type: ApplicationFiled: December 17, 2009Publication date: June 24, 2010Applicant: BASF AKTIENGESSELLSCHAFTInventors: Eberhard Ammermann, Reinhard Stierl, Gisela Lorenz, Ulrich Schöfl, Siegfried Strathmann, Klaus Schelberger, Thomas Christen
-
Publication number: 20100144725Abstract: A method of controlling or preventing pathogenic damage and/or pest damage in a plant propagation material, a plant, part of a plant and/or plant organ that grow at a later point in time, which comprises applying on the plant, part of the plant, plant organ, plant propagation material or a surrounding area thereof a combination comprising (I) one or more of a defined strobilurin compound selected from azoxystrobin, trifloxystrobin and fluoxastrobin, (II) one or more of a defined DMI: triazole compound selected from difenoconazole, prothioconazole, tebuconazole and triticonazole, and (III) one or more further defined fungicide selected fludioxonil, thiabendazole and ipconazole, in any desired sequence or simultaneously, provided the combination does not consist essentially of azoxystrobin, tebuconazole and fludioxonil.Type: ApplicationFiled: March 1, 2008Publication date: June 10, 2010Applicant: SYNGENTA CROP PROTECTION, INC.Inventors: Franz Brandl, Ronald Zeun, Michael Oostendorp
-
Patent number: 7732374Abstract: A fungicidal mixture comprising prothioconazole or its salts or adducts and at least one insecticide selected from the group consisting of fipronil, chlorpyrifos or thiamethoxam.Type: GrantFiled: July 17, 2007Date of Patent: June 8, 2010Assignee: BASF SEInventors: Eberhard Ammermann, Reinhard Stierl, Gisela Lorenz, Siegfried Strathmann, Klaus Schelberger, V. James Spadafora, Thomas Christen
-
Patent number: 7713970Abstract: Certain novel phenyl substituted cyclic urea derivatives have unexpected insecticidal activity. These compounds are represented by formula I: where A, B a, D, b, E, G, c, d, J, X and R through R10, inclusively, are fully described herein. In addition, compositions comprising an insecticidally effective amount of at least one compound of formula I, and optionally, an effective amount of at least one of a second compound, with at least one insecticidally compatible carrier are also disclosed; along with methods of controlling insects comprising applying said compositions to a locus where insects are present or are expected to be present.Type: GrantFiled: May 18, 2005Date of Patent: May 11, 2010Assignee: FMC CorporationInventors: Edward J. Barron, Larry Y. Zhang, John W. Lyga, Matthew P. Whiteside
-
Publication number: 20100113447Abstract: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a pharmaceutical composition comprising such a compound.Type: ApplicationFiled: August 10, 2009Publication date: May 6, 2010Inventors: Joseph A. Burlison, Shijie Zhang, Weiwen Ying, Dinesh U. Chimmanamada, Minghu Song, Junghyun Chae, Stefan M. Schweizer
-
Publication number: 20100105559Abstract: An agrochemical composition includes a homogeneous single-phase liquid crystal in thermodynamic equilibrium. The agrochemical composition can be a surfactant composition or a pesticide composition. The surfactant composition is a blend of surfactants, whereas a pesticide composition has an active ingredient and one or more surfactant adjuvants. A pesticide composition, or a surfactant composition in combination with an active ingredient, may be used to control pests.Type: ApplicationFiled: October 9, 2007Publication date: April 29, 2010Applicant: Huntsman Petrochemical CorporationInventors: Curtis M. Elsik, Joe C. Arzola, Howard M. Stridde, Alan Stern
-
Publication number: 20100105669Abstract: The present invention relates to a composition containing (A) at least one specific carbamate fungicide, (B) at least one specific insecticide and optionally (C) at least one azole, the use of this composition for improving plant health and a method for improving plant health by treating a plant, its propagules or the locus where the plant is growing or is to grow with the above composition.Type: ApplicationFiled: February 5, 2008Publication date: April 29, 2010Applicant: BASF SEInventors: Dirk Voeste, Egon Haden, Marco-Antonio Tavares-Rodrigues, Edson Begliomini
-
Publication number: 20100099725Abstract: The present invention is directed to compounds of the structural Formula: wherein: R1 is H or —C1-C3 alkyl; R2 is selected from the group consisting of —H, —C1-C4 alkyl, —C1-C3 alkyl-CF3, phenyl, and pyridinyl; and R3 is selected from the group consisting of —H, —C1-C4 alkyl, —C1-C3 alkyl-O—CH3, —CH2-cyclopropyl, CH2—C?CH2, —CH2CH2-(2-F-phenyl), and phenyl substituted with from 1 to 2 fluorines; provided that when R1 and R2 are each H, then R3 is selected from the group consisting of —C1-C4 alkyl, —C1-C3 alkyl-O—CH3, —CH2-cyclopropyl, —CH2—C?CH2, —CH2CH2-(2-F-phenyl), and phenyl substituted with from 1 to 2 fluorines; or stereoisomers and pharmaceutically acceptable salts thereof.Type: ApplicationFiled: February 12, 2008Publication date: April 22, 2010Inventors: Lance Allen Pfeifer, Tianwei Ma, Nathan Bryan Mantlo, Laura Frey Michael, Fese Mambo Mokube, Chahrzad Montrose-Rafizadeh
-
Publication number: 20100093717Abstract: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of treating or inhibiting angiogenesis in a subject in need thereof and methods for blocking, occluding, or otherwise disrupting blood flow in neo vasculature, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.Type: ApplicationFiled: August 14, 2007Publication date: April 15, 2010Inventors: Weiwen Ying, Kevin Foley
-
Patent number: 7683087Abstract: A series of S-triazolyl ?-mercaptoacetanilides having N-(?-mercaptoacetyl) p amino benzoic acid derivatives. are provided, where Q is CO2H, or a salt or ester thereof, or a C(O) N-linked amino acid. The compounds inhibit several variants of the reverse transcriptase of HIV, and are useful in the treatment of HIV infections.Type: GrantFiled: August 18, 2008Date of Patent: March 23, 2010Assignee: Ardea Biosciences, Inc.Inventors: Jean-Luc Girardet, Martha de la Rosa, Zhi Hong, Stanley Lang
-
Patent number: 7683086Abstract: The invention relates to a fungicidal mixture that comprises (1) 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazolo-3-thion (prothioconazole) or the salts or adducts thereof and at least one further fungicidal composition, selected from (2) boscalid or (3) carboxine or (4) metrafenone or (5) a compound of formula (V) or (6) a compound of formula (VI) or (7) quinoxyfen or (8) dithianon or (9) thiram or (10) mepiquat chlorides or (11) cyazofamid or (12) fenoxanil or (13) a compound of formula (XIII) or (14) thiophanate methyl or (15) carbendazim or (16) metalaxyl or (17) fludioxonil or (18) thiabendazole or (19) quintozene or (20) prochloraz or (21) anthraquinone in a synergistically effective amount.Type: GrantFiled: March 19, 2003Date of Patent: March 23, 2010Assignee: BASF AktiengesellschaftInventors: Eberhard Ammermann, Reinhard Stierl, Gisela Lorenz, Ulrich Schöfl, Siegfried Strathmann, Klaus Schelberger, Thomas Christen
-
Publication number: 20100063039Abstract: Process for the protection of fish and invertebrates and all their stages of development against or for the treatment of mycoses caused by fungi of the genera Saprolegnia, Aphanomyces, Achlyaflagellata and other species important in aquacultures by use of 2-[[[[1-[3-(1-fluoro-2-phenylethyl)oxy]phenyl]ethylidene]amino]oxy]methyl]alpha-(methoxyimino)-N-methyl-alphaE-benzeneacetamide, amisulbrom, cyazofamid, enestrobin, famoxadone, fenamidone, fluoxastrobin, orysastrobin, picoxystrobin and pyribencarb. This use leads to an inhibition or destruction of pathogenic fungi. The composition, comprising at least one fungicide selected from the abovementioned group for use in fish farming and keeping is suitable for the prophylaxis and therapy of diseases of fish in aquaculture, in breeding ponds, breeding tanks, aquariums, natural stretches of game fish waters, ponds, and marine fish farms. Addition to the water and feed and direct application are the associated use forms.Type: ApplicationFiled: April 8, 2008Publication date: March 11, 2010Inventors: Isolde Häuser-Hahn, Klaus Stenzel, Ulrike Wachendorff-Neumann
-
Publication number: 20100056464Abstract: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.Type: ApplicationFiled: September 3, 2009Publication date: March 4, 2010Applicant: Ardea BiosciencesInventors: Esmir Gunic, Jean-Luc Girardet, Jean-Michel Vernier, Martina E. Tedder, David A. Paisner
-
Publication number: 20100056465Abstract: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.Type: ApplicationFiled: September 4, 2009Publication date: March 4, 2010Applicant: Ardea BiosciencesInventors: Esmir Gunic, Jean-Luc Girardet, Jean-Michel Vernier, Martina E. Tedder, David A. Paisner
-
Publication number: 20100056526Abstract: A compound represented by the formula (I): wherein R1 is an oxo group, ?N—R or the like; a group represented by the formula: is a group represented by the formula: R2 is a group represented by the formula: or a salt thereof. The compound of the present invention is useful as a drug for the prophylaxis or treatment of circulatory diseases, metabolic diseases and/or central nervous system diseases.Type: ApplicationFiled: November 21, 2007Publication date: March 4, 2010Inventors: Takanobu Kuroita, Hiroki Sakamoto, Hideyuki Igawa, Minoru Sasaki, Kouhei Asano, Tsuyoshi Maekawa
-
Publication number: 20100048594Abstract: The invention relates to compounds selected from among the group comprising general formulas (1), (2), (3), and/or (4) and/or the enantiomers, diastereomers, and derivatives thereof, and the pharmaceutically acceptable salts thereof for producing a medicament used for therapeutically and/or preventively treating disease and pathological conditions linked to regulation of the insulin and/or insulin-like growth factor (IGF) signalling pathway and/or for chemically inducing longevity.Type: ApplicationFiled: November 14, 2007Publication date: February 25, 2010Applicant: RHEINISCHE FRIEDRICH-WILHELMS UNIVERSITATInventors: Michael Famulok, Markus Hafner, Anton Schmitz, Bernhard Fuss, Ingo Zinke, Michael Hoch
-
Patent number: 7666891Abstract: The present invention relates to a compounds according to formula I, methods for treating diseases mediated by human immunodeficiency virus by administration of a compound according to formula I and pharmaceutical compositions for treating diseases mediated by human immunodeficiency virus containing a compound according to formula I where R1, R2, R3, R4, R5, are as defined herein.Type: GrantFiled: July 27, 2005Date of Patent: February 23, 2010Assignee: Roche Palo Alto LLCInventors: James Patrick Dunn, Todd Richard Elworthy, Dimitrios Stefanidis, Zachary Kevin Sweeney
-
Patent number: 7662813Abstract: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.Type: GrantFiled: August 17, 2006Date of Patent: February 16, 2010Assignee: Synta Pharmaceuticals Corp.Inventors: Weiwen Ying, David James, Shijie Zhang, Teresa Przewloka, Elena Kostik, Junghyun Chae, Howard P Ng, Zhenjian Du, James Barsoum, Dinesh Chimmanamada, Chi-Wan Lee, Kevin Foley
-
Publication number: 20100022540Abstract: Novel triazole derivatives of the formula (I) in which R1—R6 and Y have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.Type: ApplicationFiled: April 20, 2007Publication date: January 28, 2010Inventors: Hans-Michael Eggenweiler, Michael Wolf, Hans-Peter Buchstaller, Christian Sirrenberg
-
Patent number: 7652051Abstract: Heterocyclic compounds derived from benzotriazine, triazines, triazoles and oxadiazoles are disclosed. The methods of synthesis and of use of such heterocyclic compounds are also provided.Type: GrantFiled: August 24, 2005Date of Patent: January 26, 2010Assignee: TargeGen, Inc.Inventors: Wolfgang Wrasidlo, Elena Dneprovskaia
-
Publication number: 20100016392Abstract: In one aspect, this invention relates to a substantially water-insoluble pesticidal aggregate produced from a mixture comprising: (a) a polymer having at least three similarly charged electrostatic moieties; (b) an amphiphilic surfactant having at least one electrostatically charged moiety of opposite charge to the polymer; and (c) a pesticide. In other aspects, this invention relates pesticidal compositions comprising such a pesticidal aggregate and an agriculturally acceptable carrier, as well as to a method of controlling pests using such pesticidal compositions.Type: ApplicationFiled: December 13, 2007Publication date: January 21, 2010Applicant: Innovaform Technologies, LLCInventors: Alexander V. Kabanov, Michael Karas, Tatiana K. Bronitch, Robin Dexter
-
Publication number: 20090312381Abstract: The present application relates to novel, substituted 4-arylimidazol-2-ones and 5-aryl-1,2,4-triazolones, processes for the production thereof, the use thereof alone or in combinations for the treatment and/or prevention of diseases and the use thereof for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases.Type: ApplicationFiled: May 21, 2007Publication date: December 17, 2009Applicant: BAYER HEALTHCARE AGInventors: Heinrich Meier, Eckhard Bender, Ulf Brüggemeier, Ingo Flamme, Dagmar Karthaus, Peter Kolkhof, Daniel Meibom, Dirk Schneider, Verena Voehringer, Chantal Fürstner, Jörg Keldenich, Dieter Lang, Elisabeth Pook, Carsten Schmeck
-
Publication number: 20090291967Abstract: Compounds, particularly compounds having activity as modulators of cadherin-mediated cell adhesion having the following structure: or a pharmaceutically acceptable salt, stereoisomer or prodrug thereof, wherein R1, R2, R3, R4, R5, R6, A, X, Y, Z, m and n are as defined herein. Methods associated with preparation and use of the same, as well as pharmaceutical compositions containing the same, are also disclosed.Type: ApplicationFiled: March 5, 2009Publication date: November 26, 2009Applicant: ADHEREX TECHNOLOGIES, INC.Inventors: Mukur Gupta, Brian Huber, Orest W. Blaschuk
-
Patent number: 7618971Abstract: The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.Type: GrantFiled: June 27, 2005Date of Patent: November 17, 2009Assignee: Merck & Co. Inc.Inventors: Paul J. Coleman, Christopher D. Cox, Mark E. Fraley, George D. Hartman, John Schreier
-
Publication number: 20090274632Abstract: The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the invention relates to the discovery of specific compounds and compositions containing that function as bitter taste blockers and the use thereof as bitter taste blockers or flavor modulators in, e.g., coffee and coffee flavored foods, beverages and medicaments. Also, the present invention relates to the discovery of a compound that antagonizes numerous different human T2Rs and the use thereof in assays and as a bitter taste blocker in compositions for ingestion by humans and animals.Type: ApplicationFiled: August 19, 2008Publication date: November 5, 2009Applicant: Senomyx, Inc.Inventors: Xiaodong Li, Andrew Patron, Catherine Tachdjian, Hong Xu, Qing Li, Alexey Pronin, Guy Servant, Lan Zhang, Thomas Brady, Vincent Darmohusodo, Melissa Arellano, Victor Selchau, Brett Weylan Ching, Donald S. Karanewsky, Paul Brust, Jing Ling, Wen Zhao, Chad Priest
-
Publication number: 20090264474Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein A, B, G, Y, R1, R2, R3, and R4 are defined herein.Type: ApplicationFiled: July 18, 2008Publication date: October 22, 2009Inventors: Shawn T. Branum, Raymond W. Colburn, Scott L. Dax, Christopher M. Flores, Michele C. Jetter, Yi Liu, Donald Ludovici, Mark J. Macielag, Jay M. Matthews, James J. McNally, Laura M. Reaney, Ronald K. Russell, Ning Qin, Christopher Teleha, Kenneth M. Wells, Scott C. Youells, Mark A. Youngman
-
Publication number: 20090239748Abstract: The present invention relates to fungicidal mixtures comprising, as active components, 1) at least one 2,5-disubstituted N-biphenylpyrazolecarboxamide of the formula I in which X=oxygen or sulfur; R1 and R2=cyano, nitro, halogen, C1-C6-alkyl, C1-C6-haloalkyl, methoxy, difluoromethoxy or trifluoromethoxy; R3=halogen, C1-C4-alkyl or C1-C4-haloalkyl; R4=hydrogen or halogen; and 2) at least one active compound II selected from groups A) to F): A) azoles; B) strobilurins; C) carboxamides; D) heterocyclic compounds; E) carbamates; F) other fungicides; in a synergistically effective amount, methods for controlling harmful fungi using mixtures of at least one compound I and at least one active compound II, the use of the compound(s) I with active compounds II for preparing such mixtures and also compositions and seed comprising these mixtures.Type: ApplicationFiled: June 28, 2006Publication date: September 24, 2009Applicant: BASF AktiengesellschaftInventors: Jochen Dietz, Markus Gewehr, Siegfried Strathmann, Reinhard Stierl, Frank Werner, Maria Scherer
-
Publication number: 20090227640Abstract: The present application relates to novel heterocyclic compounds, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prevention of cardiovascular disorders.Type: ApplicationFiled: October 9, 2006Publication date: September 10, 2009Applicant: BAYER HEALTHCARE AGInventors: Stephan Bartel, Michael Hahn, Wahed Ahmed Moradi, Klaus Münter, Thomas Rölle, Johannes-Peter Stasch, Karl-Heinz Schlemmer, Frank Wunder
-
Publication number: 20090215775Abstract: Compounds of formula (I) are disclosed for treatment of cancer.Type: ApplicationFiled: May 16, 2006Publication date: August 27, 2009Inventors: Huw David Lewis, Timothy Harrison, Mark Steven Shearman
-
Publication number: 20090197825Abstract: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.Type: ApplicationFiled: November 26, 2008Publication date: August 6, 2009Applicant: ARDEA BIOSCIENCES, INC.Inventors: Barry D. QUART, Jean-Luc GIRARDET, Esmir GUNIC, Li-Tain YEH
-
Publication number: 20090192205Abstract: A process for the release of a biologically active species comprising the steps of: providing a mesoporous oxide-based material having structural order and at least one level of porosity; fixing or immobilizing said biologically active species in said ordered mesoporous oxide; and providing said ordered mesoporous oxide with said fixed or immobilized biologically active species in vivo thereby realizing intraluminally induced substantially pH-independent supersaturation of said biologically active species resulting in enhanced transepithelial transport; wherein said biologically active species is a poorly soluble therapeutic drug classified as belonging to Class II or Class IV of the Biopharmaceutical Classification System and said ordered mesoporous oxide has a pore size in the range of 4 to 14 nm.Type: ApplicationFiled: January 28, 2009Publication date: July 30, 2009Applicant: Katholieke Universiteit Leuven K.U. Leuven R&DInventors: Patrick AUGUSTIJNS, Johan Adriaan Martens, Randy Mellaerts, Guy Van Den Mooter
-
Publication number: 20090156560Abstract: Disclosed herein are compounds that are tissue-nonspecific alkaline phosphatase inhibitors. The disclosed compounds are used to treat, prevent, or abate vascular calcification, arterial calcification and other cardiovascular diseases.Type: ApplicationFiled: May 8, 2008Publication date: June 18, 2009Inventors: JOSE LUIS MILLAN, EDUARD SERGIENKO
-
Publication number: 20090143416Abstract: A method of inducing tolerance of plants against bacterioses which comprises treating the plants, the soil or seeds with an effective amount of a combination of a compound of the formula I in which X is halogen, alkyl or trifluoromethyl; m is 0 or 1; Q is C(?CH—CH3)—COOCH3, C(?CH—OCH3)—COOCH3, C(?N—OCH3)—CONHCH3, C(?N—OCH3)—COOCH3, N(—OCH3)—COOCH3, or a group Q1 ?wherein # denotes the bond to the phenyl ring; A is —O—B, —CH2O—B, —OCH2—B, —CH2S—B, —CH?CH—B, —C?C—B, —CH2O—N?C(R1)—B, —CH2S—N?C(R1)—B, —CH2O—N?C(R1)—CH?CH—B, or —CH2O—N?C(R1)—C(R2)?N—OR3, where B is phenyl, naphthyl, 5- or 6-membered hetaryl or 5- or 6-membered heterocyclyl, containing one to three N atoms and/or one O or S atom or one or two O and/or S atoms, the ring systems being unsubstituted or substituted as defined in the description; R1 is hydrogen, cyano, alkyl, haloalkyl, cycloalkyl, alkoxy, or alkylthio; R2 is phenyl, phenylcarbonyl, phenylsulfonyl, 5- or 6-membered hetaryl, 5- or 6-membered hetarylcarbonyl or 5- or 6-membereType: ApplicationFiled: March 6, 2007Publication date: June 4, 2009Inventors: Harald Kohle, Ted R. Bardinelli, Marco-Antonio Tavares-Rodrigues
-
Publication number: 20090131438Abstract: A compound represented by the formula (I) below or a pharmaceutically acceptable salt thereof has an effect of inhibiting binding between S1P and its receptor Edg-1(S1P1), and is useful as a pharmaceutical product. [where A represents a sulfur atom, an oxygen atom, a formula —SO— or a formula —SO2—; R1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or the like; R2 represents an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms or the like; R3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R4 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a phenyl group or the like; R5 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and R6 represents an alkyl group having 1 to 6 carbon atoms, a phenyl group or a substituted phenyl group].Type: ApplicationFiled: August 4, 2005Publication date: May 21, 2009Applicant: Taisho Pharmaceutical Co., LtdInventors: Naoya Ono, Masakazu Sato, Fumiyasu Shiozawa, Makoto Yagi, Tetsuya Yabuuchi, Tetsuo Takayama, Hironori Katakai
-
Publication number: 20090131462Abstract: The invention relates to a fungicidally active agent containing at least one other defined fungicide in addition to the fungicide N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluormethyl)-1H-pyrazol-4-carboxamide (penthiopyrad). The invention also relates to a method for controlling pathogenic fungi using one such agent, and to the use of said agent for controlling pathogenic fungi.Type: ApplicationFiled: July 21, 2006Publication date: May 21, 2009Applicant: BASF AKTIENGESELLSCHAFTInventors: Markus Gewehr, Reinhard Stierl, Horst Dieter Brix, Thomas Grote, Siegfried Strathmann, Maria Scherer, Frank Werner
-
Publication number: 20090124679Abstract: The present invention provides a fungicide composition having stable and high harmful bio-organism control effect on crop plants infected with plant diseases due to plant diseases. Specifically, the present invention provides a fungicide composition for agricultural or horticultural use, which comprises: (a) an indole compound represented by formula (I): wherein R1 and R2 each independently represents C1-4 alkyl, etc.; Y represents H, halogen, etc.; R3 and R4 each independently represents a hydrogen atom, alkyl, etc.; R5, R6, R7 and R8 each independently represents a hydrogen atom, alkyl, etc., and (b) at least other fungicide selected from the group consisting of Dimethomorph, Chlorothalonil, a copper compound, Iprovalicarb, Zoxamide, phosphorous acid or a salt thereof, Fluazinam, Cyazofamid, Flumorph, Benthiavalicarb-isopropyl, Ethaboxam, Methalaxyl-M and Benalaxyl-M.Type: ApplicationFiled: October 21, 2005Publication date: May 14, 2009Applicant: ISHIHARA SANGYO KAISHA, LTD.Inventor: Shigeru Mitani
-
Patent number: 7531566Abstract: Novel compounds and methods of using those compounds for the treatment of inflammatory conditions are provided. In a preferred embodiment, modulation of the activation state of p38 kinase protein comprises the step of contacting the kinase protein with the novel compounds.Type: GrantFiled: January 20, 2006Date of Patent: May 12, 2009Assignee: Deciphera Pharmaceuticals, LLCInventors: Daniel L. Flynn, Peter A. Petillo
-
Publication number: 20090111857Abstract: The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.Type: ApplicationFiled: October 24, 2008Publication date: April 30, 2009Applicant: AstraZeneca ABInventors: Peter DOVE, Kenneth Granberg, Methvin Isaac, Mats Nagard, Abdelmalik Slassi
-
Patent number: 7524863Abstract: The present application describes sulfonylaminovalerolactams and derivatives thereof of Formula I: or pharmaceutically acceptable salt forms thereof, wherein ring G is a mono- or bicyclic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.Type: GrantFiled: June 21, 2006Date of Patent: April 28, 2009Assignee: Bristol-Myers Squibb CompanyInventors: Joanne M. Smallheer, Donald J. Pinto, Shuaige Wang, Jennifer X. Qiao, Wei Han, Zilun Hu